
Pallas Health review
By Nadia Feldman · Aminoscope
Flat dose pricing, named pharmacies
Our verdict
Pallas lists introductory compounded GLP-1 prices and four-week renewals with care and shipping included. Use the semaglutide price comparison to match the first and recurring charges to the supplied period, since four-week renewals differ from calendar months. Confirm the exact medication and assigned pharmacy before paying, particularly where its branded listings show different starting figures.
Main trade-offs
- Once a prescription is issued, that cycle is final and is not prorated if you cancel
- Brand-name pricing differs across the page: pens are advertised at $499 first, then from $599 every four weeks, while Mounjaro is listed from $1,099/mo
Disclosure: Aminoscope is reader-supported. We may earn a commission from partner links, at no extra cost to you. This never changes our assessment. How we make money.
Compounded medicines are not FDA-approved. A licensed clinician must assess whether treatment is appropriate; availability does not establish safety or benefit.
Good fit
Buyers who want a compounded GLP-1 price that will not climb as they titrate, who want to know which pharmacies may fill it, or who want brand-name and compounded options from the same service.
Consider other options if
Anyone who wants a routine prorated refund after a prescription is issued, or a single unambiguous advertised price for a brand-name plan.
Cost and care at a glance
- Category
- GLP-1 telehealth
- Published cost
- Semaglutide $199 every 4 weeks ($139 first month); tirzepatide $299 ($179 first month) — flat at every dose, charged only once prescribed; 50 states + D.C.
- Medications
- Compounded semaglutide · Compounded tirzepatide · Brand Wegovy / Ozempic / Zepbound / Mounjaro
- Insurance
- Cash-pay, no insurance
- Visit
- Quiz intake / Async intake
- Availability
- All 50 states plus Washington, D.C. (a video visit is required in AR, MS, NM, ND, RI, SD, WV and D.C.)
- LegitScript
- Claimed by provider
Our review in detail
Full assessment
Pallas gets right the things this category most often gets wrong. Its compounded price does not rise as your dose does, and it says so plainly. You pay nothing until a clinician actually prescribes. It names its clinical partner and all seven of the pharmacies that may fill your prescription, and its advising physician's NPI number links straight to the federal registry. Billing is simple: compounded semaglutide is $139 for the first month and then $199 every four weeks, and tirzepatide $179 and then $299, renewing until you cancel. The reservations are narrow. Once a prescription is issued, that cycle is final and is not prorated if you cancel. The "4.8/5 from 2,400+ member reviews" and "200,000+ patients" figures name no source. Its homepage and GLP-1 page advertise brand-name pens at $499 for the first month, then from $599 every four weeks, but the same GLP-1 page lists Mounjaro from $1,099/mo. Confirm the selected drug, dose, first charge and renewal price before comparing brand-name plans.
What it is
A cash-pay telehealth service operated by Brentmoor, Inc. Its core is weight loss: compounded semaglutide and tirzepatide injections, plus FDA-approved Wegovy, Ozempic, Zepbound and Mounjaro pens and the Wegovy pill and Foundayo tablets at cash-pay rates. Around that it sells a wider menu: NAD⁺ and sermorelin, a glutathione injection, women's hormone therapy (progesterone capsules, estradiol patch, estradiol vaginal cream and a biest-plus-progesterone cream), compounded skincare (including tretinoin and an estriol face cream), and sildenafil or tadalafil tablets for men. The Gala Health review covers a program built around women’s weight and hormone care, with compounded pricing tied to a yearly plan. A free app handles messaging, refills and dose and weight logging.
How care works
A short online health questionnaire is reviewed by a U.S.-licensed clinician, typically within one business day and often the same day; the pharmacy usually ships within two to three business days, so most members have their first shipment within a week. In 43 states the visit is fully asynchronous. Arkansas, Mississippi, New Mexico, North Dakota, Rhode Island, South Dakota, West Virginia and Washington, D.C. require one short video visit, booked right after checkout. Pallas is explicit that it is a technology platform that does not employ clinicians, practice medicine or direct clinical decisions: care is delivered by Lion MD, a nationwide group of U.S.-licensed clinicians, with CareValidate handling licensure checks and dispensing. Every prescriber holds an active license in your state, and you are given your clinician's name and license details before any prescription is issued. The advising physician, Dr. Ana Lisa Carr, MD (family, obesity and addiction medicine), is named with her NPI number and a link to verify it in the federal registry. Prescriptions go to one of seven named partner pharmacies, depending on the medication, your state and capacity: Belmar Pharmacy, Strive Pharmacy, Epiq Scripts, Casa Pharma Rx, The Pharmacy Hub, Foothills Pharmacy and Evoluciona Pharma, with state license numbers available on request. After that, care runs through the app and portal: messages, phone or a scheduled video check-in, dose adjustments and refills. LegitScript certified.
Costs, billing and cancellation
The compounded plans are one price at every dose, with clinician visits, follow-ups, messaging and shipping included and no membership fee, and nothing is charged until a clinician prescribes. Compounded semaglutide is $139 for the first month and then $199 every four weeks; tirzepatide is $179 and then $299 every four weeks. Both renew until you cancel. Annual plans advertise averages of $139 and $239 a month. These averages are not the amount of a recurring four-week charge: confirm the annual first payment, supply and renewal terms. The Terms describe charging the selected monthly, quarterly, six-month or annual plan when prescribed, with renewal at that plan price and billing period.
NAD⁺ (a weekly injection) and sermorelin are each $139 for the first month and then $179 every four weeks ($119 a month on the annual plan); glutathione is $199 every four weeks. Billing periods matter here, and the Live Vital review explains protocol pricing, where semaglutide is sold as a ten-week course rather than by calendar month. The FDA-approved tablets, the Wegovy pill and Foundayo, are $299 for the first month and then $499 every four weeks. Its homepage and GLP-1 page advertise brand-name pens at $499 for the first month, then from $599 every four weeks, but the same GLP-1 page lists Mounjaro from $1,099/mo. Confirm the selected drug, dose, first charge and renewal price before comparing brand-name plans.
Women's hormone therapy is billed per 12-week supply ($129 to $399), ED tablets per 30-, 60- or 90-day supply (from $49 for a month, $25 a month on 90 days). Cash-pay only, FSA and HSA accepted, and pay-over-time is offered at checkout.
Refunds depend on purchase date. The Terms apply the current policy to plans bought on or after September 8, 2026: no charge before prescribing, a full refund of any charge if not approved, and no routine refund or proration after the prescription is issued. Canceling is free and stops future charges. A damaged or compromised shipment reported within 24 hours is replaced or refunded. Earlier purchases have separate terms, including possible processing costs plus a $5 fee for qualifying customer-requested refunds from July 14. The homepage instead labels its current policy as applying from July 14, so ask Pallas which dated terms apply to your purchase.
And a "6-month promise": stay on a paid plan for six continuous months, follow it and log your weights, and if you lost no net weight or are unhappy, you can claim back the plan payments for those six months within 30 days.
Medication and evidence
Both compounded and brand-name, and the distinction is disclosed properly. Pallas's own disclosure states that compounded medications are not FDA-approved and are not generic versions of brand-name drugs, that it does not manufacture or compound medication itself, and that what you receive may differ in appearance from any product shown on the site. Compounded semaglutide and tirzepatide are prepared by 503A compounding pharmacies or 503B outsourcing facilities from its named list, and its clinical page adds that compounding requires a documented patient-specific clinical need, not price alone. The brand-name line is the real thing (FDA-approved Wegovy, Ozempic, Zepbound and Mounjaro pens, plus the Wegovy pill and Foundayo), which matters because the trial evidence for these molecules belongs to the approved products, not to compounded copies of them. NAD⁺ is a weekly subcutaneous injection with clinician-set dosing. No controlled human outcome trial supports injected NAD⁺; the randomized evidence sits with the oral NR and NMN precursors, and it shows a raised blood NAD⁺ level rather than a proven clinical benefit. Pallas is restrained here: its NAD⁺ page describes the coenzyme's role in energy metabolism, marks its figures "illustrative and educational only" and makes no outcome promise. Its sermorelin page explains the drug accurately, as a copy of the first 29 amino acids of growth-hormone-releasing hormone that prompts your own pituitary, lists the common side effects, and cites the clinical studies it relies on; long-term outcome data for sermorelin remain thin. Individual results vary.
Pros and watch-outs
What we like
- The compounded price is the same at every dose, and the site says so plainly
- Nothing is charged until a clinician prescribes; if you are not approved you pay nothing
- Billing every four weeks ($199 semaglutide, $299 tirzepatide after the first month), not quarterly
- Names its clinical partner (Lion MD) and all seven partner pharmacies
- Advising physician's NPI number links to the federal registry
- Genuine brand-name pens and the Wegovy pill and Foundayo alongside compounded options
- A six-month money-back promise if you follow the plan and lose no net weight
- LegitScript certified; all 50 states plus D.C.; restrained NAD⁺ marketing with no outcome claims
Watch-outs
- Once a prescription is issued, that cycle is final and is not prorated if you cancel
- Brand-name pricing differs across the page: pens are advertised at $499 first, then from $599 every four weeks, while Mounjaro is listed from $1,099/mo
- "200,000+ patients" and "4.8/5 from 2,400+ member reviews" name no source or review platform
- A video visit is required in seven states and D.C.
- Annual-plan averages of $139 and $239/mo are not four-week bills; confirm the first payment, supply and renewal terms
Best for
Buyers who want a compounded GLP-1 price that will not climb as they titrate, who want to know which pharmacies may fill it, or who want brand-name and compounded options from the same service.
Who should look elsewhere
Anyone who wants a routine prorated refund after a prescription is issued, or a single unambiguous advertised price for a brand-name plan.
Research relevant to Pallas Health
Explore the evidence and its limits. Findings apply to the formulation, route and population studied; they do not establish the quality or effectiveness of a provider’s products.
- What the semaglutide weight-loss trials actually showed
STEP 1, STEP 4 and SELECT, plus oral and higher-dose semaglutide trials: weight loss, withdrawal, cardiovascular benefit and the limits of comparison.
- Tirzepatide vs semaglutide for weight loss: what the trials actually support
SURMOUNT-5 found 20.2% versus 13.7% average weight loss. What that direct comparison supports, which doses it tested, and why newer formulations need separate evidence.
- NAD+ precursors (NR and NMN): what the human trials actually show
They raise NAD+ and look safe short-term, but human evidence is surrogate-marker level, and no trial shows they extend healthspan.
- Sermorelin benefits: does it work? What the trials show
A real GHRH drug, read against the anti-aging pitch: an approved growth-hormone-releasing analog with a pediatric track record, and a longevity case built more on biomarkers than outcomes.
How Pallas Health compares
A few alternatives worth a look, depending on what you’re optimizing for.
Our Found review and yourEra review describe what each service publishes about pricing, billing and cancellation.
FoundMultiple medication pathways and insurance for clinical visits
See Found →
yourEraComparing monthly billing and longer terms for compounded GLP-1 care
See yourEra →
the edit.Buyers who want the management company and practice identified and will confirm the dispensing pharmacy
See the edit. →
More GLP-1 telehealth reviews: KovaLoozyRaelivaLeland HealthShapeIn RxMD Live
Access & cost
How we assessed this. This review is based on Pallas Health’s own website and published terms, read for pricing transparency, clinical oversight, medication clarity and access against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.
Frequently asked
- Does the price go up as my dose increases?
- No, for the compounded plans. Pallas states that your compounded plan costs the same at every dose, from starting dose to maintenance: semaglutide is $139 for the first month and then $199 every four weeks on any dose, tirzepatide $179 and then $299. The GLP-1 page also says brand-name plans cost the same at every dose, but its umbrella pen price and Mounjaro card differ. Ask for the selected drug and dose quote rather than applying one advertised figure to every brand.
- Is the "$199" a monthly bill?
- The advertised $199 semaglutide renewal is every four weeks, not per calendar month. Tirzepatide is advertised at $299 every four weeks after its first month. The lower $139/mo and $239/mo figures are annual-plan averages, not four-week bills. The Terms say the selected plan is charged when prescribed and renews at that plan price and billing period; confirm the first payment and supply for the plan you choose.
- What is Pallas's six-month promise?
- If you stay on a paid plan for six continuous months, take your doses on schedule, do your check-ins and log your starting and six-month weights in the portal, and you lost no net weight or are unhappy after the care team has tried to help, you can claim back the plan payments for those six months within 30 days of the six-month mark. One claim per patient. Pallas calls it a commercial commitment, not a medical guarantee.
- Should I buy brand-name Wegovy or Zepbound through Pallas?
- Its homepage and GLP-1 page advertise brand-name pens at $499 for the first month, then from $599 every four weeks, but the same GLP-1 page lists Mounjaro from $1,099/mo. Confirm the selected drug, dose, first charge and renewal price before comparing brand-name plans. The pen offer does not establish the separate price of the Wegovy pill or Foundayo.
- Who actually prescribes and dispenses?
- Pallas describes itself as a technology platform that does not employ clinicians or practice medicine. Care comes from Lion MD, a nationwide group of U.S.-licensed clinicians, with CareValidate handling licensure checks and dispensing. Prescriptions are filled by one of seven named partner pharmacies (Belmar, Strive, Epiq Scripts, Casa Pharma Rx, The Pharmacy Hub, Foothills and Evoluciona Pharma), depending on the medication and your state. You are given your clinician's name and license details before any prescription is issued.
- Is Pallas Health legit?
- Pallas Health is a GLP-1 telehealth service you reach through an online questionnaire and an online intake a clinician reviews. The medications it names are Compounded semaglutide, Compounded tirzepatide and Brand Wegovy / Ozempic / Zepbound / Mounjaro. Its stated availability: All 50 states plus Washington, D.C. (a video visit is required in AR, MS, NM, ND, RI, SD, WV and D.C.). What it publishes up front: Semaglutide $199 every 4 weeks ($139 first month); tirzepatide $299 ($179 first month) — flat at every dose, charged only once prescribed; 50 states + D.C. It is cash-pay and states it does not bill insurance. It shows a LegitScript seal. Ask the company for its certificate number before you rely on it. Before you pay, ask in writing about your selected charge, billing interval, supply and required fees.